
PRX-08066
CAS No. 866206-54-4
PRX-08066( —— )
Catalog No. M24869 CAS No. 866206-54-4
PRX-08066 is a selective 5-hydroxytryptamine receptor 2B (5-HT2BR, IC50= 3.4 nM) antagonist that induces selective vasodilation of pulmonary arteries.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
5MG | 110 | In Stock |
![]() ![]() |
10MG | 160 | In Stock |
![]() ![]() |
25MG | 332 | In Stock |
![]() ![]() |
50MG | 494 | In Stock |
![]() ![]() |
100MG | 709 | In Stock |
![]() ![]() |
500MG | 1467 | In Stock |
![]() ![]() |
1G | Get Quote | In Stock |
![]() ![]() |
Biological Information
-
Product NamePRX-08066
-
NoteResearch use only, not for human use.
-
Brief DescriptionPRX-08066 is a selective 5-hydroxytryptamine receptor 2B (5-HT2BR, IC50= 3.4 nM) antagonist that induces selective vasodilation of pulmonary arteries.
-
DescriptionPRX-08066 is a selective 5-hydroxytryptamine receptor 2B (5-HT2BR, IC50= 3.4 nM) antagonist that induces selective vasodilation of pulmonary arteries.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayEndocrinology/Hormones
-
Target5-HT Receptor
-
Recptor5-HT2B
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number866206-54-4
-
Formula Weight401.89
-
Molecular FormulaC19H17ClFN5S
-
Purity>98% (HPLC)
-
SolubilityDMSO:7 mg/mL (17.42 mM; Need ultrasonic)
-
SMILESC1CN(CCC1NC2=C3C=C(SC3=NC=N2)Cl)CC4=CC(=C(C=C4)F)C#N
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Porvasnik SL, et al. PRX-08066, a novel 5-hydroxytryptamine receptor 2B antagonist, reduces monocrotaline-induced pulmonary arterial hypertension and right ventricular hypertrophy in rats. J Pharmacol Exp Ther. 2010 Aug;334(2):364-72.
molnova catalog



related products
-
Elbasvir
Elbasvir is an inhibitor of nonstructural protein 5A (NS5A) of hepatitis C virus (HCV) being developed as a component of treatment regimens for chronic HCV infection.
-
Mosapride
Mosapride is a selective 5HT4 agonist.
-
SB 737050A
SB 737050A is a potent, selective 5-HT6 receptor antagonist to prevent relapse intio addiction.